k141_172861_3	SARG|ZP_03945515	38.7	106	110	291	6.14e-14	64.7
k141_172861_3	SARG|ZP_03041263	39.6	91	110	267	2.53e-12	60.1
k141_172861_3	SARG|YP_001416709	34.6	107	110	305	1.10e-11	58.5
k141_172861_3	SARG|ZP_03941859	34.0	106	110	288	1.95e-11	57.8
k141_172861_3	SARG|ZP_03938934	34.0	106	110	288	1.95e-11	57.8
k141_172861_3	SARG|B1YIX1	35.3	102	110	278	2.39e-10	54.7
k141_172861_3	SARG|ZP_03829223	37.4	91	110	272	6.05e-10	53.5
k141_172861_3	SARG|Q2NWE3	61.9	42	110	273	6.08e-10	53.5
k141_172861_3	SARG|YP_001527590	50.0	48	110	295	6.52e-10	53.5
k141_172861_3	SARG|gi|492817089|ref|WP_005974730.1|	36.3	91	110	272	8.32e-10	53.1
k141_595540_2	SARG|gi|446048013|ref|WP_000125868.1|	28.3	219	518	648	3.62e-17	83.6
k141_595540_2	SARG|gi|926351744|ref|WP_053683383.1|	25.3	225	518	648	4.17e-07	51.6
k141_595540_2	SARG|gi|516574297|ref|WP_017949361.1|	24.9	221	518	620	5.39e-07	51.2
k141_595540_2	SARG|gi|497748188|ref|WP_010062372.1|	24.9	225	518	605	7.04e-07	50.8
k141_595540_2	SARG|gi|1045390184|ref|WP_065479071.1|	24.9	225	518	605	7.04e-07	50.8
k141_595540_2	SARG|gi|739906046|ref|WP_037756452.1|	24.9	221	518	620	7.11e-07	50.8
k141_595540_2	SARG|gi|953808775|ref|WP_058042812.1|	24.9	217	518	608	9.30e-07	50.4
k141_595540_2	SARG|gi|860594225|ref|WP_048475168.1|	25.1	251	518	620	9.38e-07	50.4
k141_595540_2	SARG|gi|639148059|ref|WP_024490169.1|	24.5	216	518	602	2.13e-06	49.3
k141_595540_2	SARG|gi|695865802|ref|WP_032778631.1|	24.4	225	518	605	2.13e-06	49.3
k141_154116_4	NCBI|QHA94808.1|1|1|narA|narA||1|MADURAMICIN/NARASIN/SALINOMYCIN|IONOPHORE|ionophore_ABC_transporter_ATP-binding_subunit_NarA|AMR|ionophore	28.2	195	243	293	2.91e-19	83.6
k141_154116_4	SARG|gb|AAK76137.1|ARO:3000024|patA	21.8	239	243	564	2.55e-10	58.9
k141_481001_1	CARD|gb|AAC75429.1|ARO:3000833|evgS	32.9	414	1180	1197	3.76e-48	186
k141_481001_1	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	30.2	129	1180	228	1.20e-09	58.9
k141_115965_1	NCBI|WP_050824634.1|1|1|tet(O)|tet(O)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(O)|AMR|tetracycline	34.9	129	292	639	4.39e-14	71.2
k141_730939_5	SARG|gi|507055561|ref|WP_016126482.1|	36.5	219	318	309	8.32e-45	154
k141_730939_5	SARG|gi|542061059|gb|ERI11611.1|	36.4	220	318	316	1.39e-44	153
k141_730939_5	SARG|gi|488053456|ref|WP_002124853.1|	36.5	219	318	309	6.37e-44	151
k141_730939_5	SARG|gi|488130770|ref|WP_002201978.1|	36.5	219	318	309	6.37e-44	151
k141_730939_5	SARG|gi|445996719|ref|WP_000074574.1|	36.5	219	318	309	8.95e-44	151
k141_730939_5	SARG|gi|488068784|ref|WP_002140181.1|	37.0	219	318	309	8.95e-44	151
k141_730939_5	SARG|gi|488067981|ref|WP_002139378.1|	36.5	219	318	309	1.26e-43	150
k141_730939_5	SARG|gi|447195835|ref|WP_001273091.1|	35.9	220	318	306	1.64e-43	150
k141_730939_5	SARG|gi|487936534|ref|WP_002010000.1|	36.7	218	318	309	1.76e-43	150
k141_730939_5	SARG|gi|507023808|ref|WP_016095885.1|	36.1	219	318	309	3.47e-43	149
k141_846263_3	SARG|gb|AAK76137.1|ARO:3000024|patA	28.7	195	373	564	7.95e-15	74.7
k141_846263_4	SARG|gb|CAE00499.1|ARO:3003835|cdeA	23.4	431	454	441	8.32e-34	130
k141_750378_10	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.0	533	655	655	5.70e-91	295
k141_750378_10	SARG|gb|AKA86814|ARO:3003746|optrA	36.0	533	655	655	5.70e-91	295
k141_750378_10	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.0	533	655	655	1.56e-90	293
k141_750378_10	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.0	533	655	655	3.05e-90	293
k141_750378_10	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.0	533	655	655	4.27e-90	292
k141_750378_10	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.0	533	655	655	4.27e-90	292
k141_750378_10	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.0	533	655	655	4.27e-90	292
k141_750378_10	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.0	533	655	655	4.27e-90	292
k141_750378_10	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.0	533	655	655	5.98e-90	292
k141_750378_10	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.0	533	655	655	8.36e-90	291
k141_808252_8	CARD|gb|ADM92605.1|ARO:3000553|adeR	30.1	183	1157	247	3.62e-13	69.7
k141_808252_8	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	28.3	120	1157	219	1.71e-10	61.2
k141_808252_8	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	28.3	120	1157	219	1.71e-10	61.2
k141_808252_8	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	28.3	120	1157	220	1.74e-10	61.2
k141_808252_8	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	29.2	120	1157	220	2.34e-10	60.8
k141_808252_8	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	27.5	120	1157	220	5.76e-10	59.7
k141_808252_8	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	26.7	105	1157	232	3.26e-08	54.7
k141_808252_8	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	26.6	109	1157	231	4.34e-08	54.3
k141_808252_8	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	25.7	152	1157	231	6.18e-07	50.8
k141_808252_8	CARD|gb|ATC67679.1|ARO:3000838|arlR	24.6	118	1157	219	9.75e-07	50.1
k141_808252_20	SARG|gb|APB03217.1|ARO:3003983|CatU	34.5	55	127	217	4.97e-09	51.2
k141_808252_20	NCBI|WP_063843212.1|1|1|catA5|catA5|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_A-5_phenicol_O-acetyltransferase|AMR|phenicol	46.0	50	127	220	9.68e-09	50.4
k141_808252_20	megares|MEG_1583|Drugs|Phenicol|Chloramphenicol_acetyltransferases|CATA_1	24.1	112	127	220	1.72e-07	47.0
k141_808252_20	SARG|K00544.gene.p01	24.1	112	127	220	1.72e-07	47.0
k141_846747_1	SARG|gb|AAG05916.1|ARO:3004073|MuxA	23.3	206	262	426	3.71e-11	61.6
k141_846747_1	SARG|gi|488899926|ref|WP_002811019.1|	23.2	207	262	385	2.44e-06	47.0
k141_846747_1	SARG|gi|488872078|ref|WP_002784303.1|	23.7	207	262	385	2.44e-06	47.0
k141_846747_1	SARG|gi|488868725|ref|WP_002780964.1|	23.7	207	262	385	2.44e-06	47.0
k141_213140_2	NCBI|WP_014936356.1|1|1|tva(B)|tva(B)|target_protection|2|TIAMULIN|PLEUROMUTILIN|ABC-F_type_ribosomal_protection_protein_Tva(B)|AMR|pleuromutilin	31.3	534	538	504	1.36e-69	231
k141_213140_2	SARG|gb|SOX29786.1|ARO:3004730|tva(A)	31.9	539	538	505	7.45e-69	229
k141_213140_2	CARD|gb|BAB80490.1|ARO:3007644|Cper_cplR	27.6	514	538	568	4.89e-27	114
k141_213140_2	NCBI|WP_172065992.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	27.1	409	538	461	8.03e-26	109
k141_213140_2	NCBI|WP_171943877.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	26.9	409	538	461	1.96e-25	108
k141_213140_2	NCBI|WP_000420317.1|1|1|msr(D)|msr(D)|target_protection|2|AZITHROMYCIN/ERYTHROMYCIN/STREPTOGRAMIN_B|MACROLIDE/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_Msr(D)|AMR|multidrug	26.6	503	538	487	3.43e-24	104
k141_213140_2	SARG|DAC81085.1	25.7	501	538	486	4.56e-24	104
k141_213140_2	NCBI|WP_000420313.1|1|1|msr(D)|msr(D)|target_protection|2|AZITHROMYCIN/ERYTHROMYCIN/STREPTOGRAMIN_B|MACROLIDE/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_Msr(D)|AMR|multidrug	26.6	503	538	487	1.48e-23	102
k141_213140_2	NCBI|WP_063856937.1|1|1|vga(A)|vga(A)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(A)|AMR|lincosamide	27.6	438	538	522	7.83e-22	97.8
k141_213140_2	SARG|gb|QQA64075.1|ARO:3007043|msr(I)	24.2	501	538	485	1.54e-21	96.7
k141_404992_9	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	25.7	167	204	255	1.07e-09	55.5
k141_23295_1	SARG|gi|556290479|ref|WP_023291164.1|	20.2	455	789	1036	8.68e-09	58.2
k141_23295_1	SARG|CP000647.1.gene3710.p01	20.2	455	789	1036	1.14e-08	57.8
k141_23295_1	SARG|gi|496667122|ref|WP_009309612.1|	20.2	455	789	1036	1.14e-08	57.8
k141_23295_1	SARG|gi|694076105|ref|WP_032421853.1|	20.2	455	789	1036	1.14e-08	57.8
k141_23295_2	SARG|YP_838977	25.7	499	957	1061	2.92e-33	137
k141_23295_2	SARG|YP_002095804	25.7	499	957	1066	2.94e-33	137
k141_23295_2	SARG|NC_010400.5984909.p01	25.3	505	957	1059	2.65e-32	134
k141_23295_2	SARG|gb|CAJ77856.1|ARO:3000777|adeF	25.1	505	957	1059	3.49e-32	134
k141_23295_2	SARG|YP_001811890	25.3	499	957	1066	3.51e-32	134
k141_23295_2	SARG|ZP_02889083	25.3	499	957	1071	3.53e-32	134
k141_23295_2	SARG|AAB58161	25.1	499	957	1027	5.83e-32	133
k141_23295_2	SARG|YP_371056	24.4	496	957	1066	6.10e-32	133
k141_23295_2	SARG|ZP_02904980	25.6	484	957	1048	7.88e-32	133
k141_23295_2	SARG|CAR56416	25.1	499	957	1066	8.04e-32	133
k141_23295_5	SARG|gi|1028199673|ref|WP_063943593.1|	22.1	240	446	371	1.23e-06	49.3
k141_23295_5	SARG|gi|1016954251|ref|WP_063154587.1|	22.1	240	446	371	1.64e-06	48.9
k141_23295_5	SARG|gi|754493746|ref|WP_041910641.1|	22.1	240	446	371	1.64e-06	48.9
k141_23295_5	SARG|gi|654544840|ref|WP_028012548.1|	21.7	240	446	371	2.17e-06	48.5
k141_791185_2	SARG|gb|AAC75314.1|ARO:3003578|pmrF	23.8	307	320	322	1.44e-20	89.4
k141_272585_4	SARG|gi|948137056|ref|WP_056795395.1|	30.1	554	720	602	5.57e-55	197
k141_272585_4	SARG|gi|926400371|ref|WP_053728483.1|	30.9	569	720	603	1.46e-54	196
k141_272585_4	SARG|gi|772774655|ref|WP_045322518.1|	30.3	568	720	620	4.98e-54	195
k141_272585_4	SARG|gi|1033217078|gb|OAR27197.1|	29.8	568	720	601	5.02e-54	195
k141_272585_4	SARG|gi|663350985|ref|WP_030349761.1|	30.7	551	720	613	8.37e-54	194
k141_272585_4	SARG|gb|AAC74000.1|ARO:3003950|msbA	28.3	488	720	582	3.33e-53	192
k141_272585_4	SARG|gi|917229923|ref|WP_051836635.1|	29.2	572	720	620	8.45e-53	192
k141_272585_4	SARG|gi|799286378|ref|WP_045936958.1|	29.6	568	720	620	1.16e-52	191
k141_272585_4	SARG|gi|917127754|ref|WP_051734466.1|	29.6	568	720	620	1.16e-52	191
k141_272585_4	SARG|gi|926294973|ref|WP_053631154.1|	29.6	568	720	620	1.16e-52	191
k141_272585_5	SARG|gi|917229923|ref|WP_051836635.1|	27.9	559	760	620	4.96e-50	184
k141_272585_5	SARG|gi|917203192|ref|WP_051809904.1|	27.7	570	760	620	9.21e-50	184
k141_272585_5	SARG|gi|926351744|ref|WP_053683383.1|	27.0	559	760	648	9.97e-50	184
k141_272585_5	SARG|gi|917166849|ref|WP_051773561.1|	27.0	555	760	620	3.16e-49	182
k141_272585_5	SARG|gi|772774655|ref|WP_045322518.1|	27.3	575	760	620	3.16e-49	182
k141_272585_5	SARG|gi|928900436|ref|WP_053931243.1|	27.4	563	760	600	3.22e-49	182
k141_272585_5	SARG|gi|664579989|ref|WP_031094015.1|	27.4	563	760	601	3.27e-49	182
k141_272585_5	SARG|gi|917155568|ref|WP_051762280.1|	27.0	555	760	620	4.30e-49	182
k141_272585_5	SARG|gi|799286378|ref|WP_045936958.1|	27.5	579	760	620	4.30e-49	182
k141_272585_5	SARG|gi|917127754|ref|WP_051734466.1|	27.5	579	760	620	4.30e-49	182
k141_426592_22	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	42.6	692	646	703	2.65e-164	486
k141_734246_2	SARG|gi|447195835|ref|WP_001273091.1|	32.9	216	232	306	1.04e-27	106
k141_734246_2	SARG|gi|500194536|ref|WP_011867743.1|	31.9	213	232	306	2.01e-27	105
k141_734246_2	SARG|gi|447195836|ref|WP_001273092.1|	32.4	216	232	306	2.81e-27	105
k141_734246_2	SARG|gi|445996709|ref|WP_000074564.1|	30.8	211	232	309	4.13e-27	104
k141_734246_2	SARG|gi|507055561|ref|WP_016126482.1|	30.5	213	232	309	4.13e-27	104
k141_734246_2	SARG|gi|542061059|gb|ERI11611.1|	32.2	227	232	316	4.64e-27	104
k141_734246_2	SARG|gi|445996710|ref|WP_000074565.1|	30.8	211	232	309	5.75e-27	104
k141_734246_2	SARG|gi|445996719|ref|WP_000074574.1|	31.1	212	232	309	1.12e-26	103
k141_734246_2	SARG|P42332	30.8	214	232	306	1.48e-26	103
k141_734246_2	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	30.8	214	232	306	1.48e-26	103
k141_792261_5	CARD|gb|AAC75429.1|ARO:3000833|evgS	31.7	369	791	1197	1.12e-40	160
k141_792261_5	NCBI|WP_063856748.1|1|1|vanS-M|vanS-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-M|AMR|glycopeptide	26.4	235	791	370	4.55e-17	82.8
k141_792261_5	NCBI|WP_006285582.1|1|1|vanS-F|vanS-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-F|AMR|glycopeptide	26.0	235	791	365	7.76e-17	82.0
k141_792261_5	CARD|gb|ADM92605.1|ARO:3000553|adeR	29.0	131	791	247	3.14e-09	57.4
k141_197065_15	SARG|gi|1002798395|gb|AMN85478.1|	37.9	372	377	343	8.29e-70	221
k141_197065_15	SARG|AAD42184	36.2	370	377	343	7.22e-68	216
k141_197065_15	SARG|gi|552941803|ref|WP_023042860.1|	36.2	370	377	343	7.22e-68	216
k141_197065_15	SARG|ACM47287	36.2	370	377	343	1.59e-66	213
k141_197065_15	SARG|AAR37060	36.4	374	377	343	8.83e-66	211
k141_197065_15	SARG|AAZ98839	36.8	367	377	343	8.83e-66	211
k141_197065_15	SARG|gi|726981187|ref|WP_033585865.1|	37.4	369	377	340	1.14e-65	211
k141_197065_15	SARG|gi|726976857|ref|WP_033582037.1|	37.4	369	377	340	1.61e-65	210
k141_197065_15	SARG|gi|748291566|ref|WP_039833224.1|	37.7	371	377	343	1.75e-65	210
k141_197065_15	SARG|ABS72058	35.4	370	377	343	1.75e-65	210
k141_658318_9	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	27.7	148	227	579	1.01e-07	50.8
k141_658318_9	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	26.4	148	227	579	1.83e-07	50.1
k141_658318_9	SARG|gb|CDO61516.1|ARO:3003949|efrB	25.5	165	227	362	2.02e-07	49.7
k141_542755_14	megares|MEG_7514|Drugs|Glycopeptide|VanL-type_regulator|VANSL_1	25.5	259	996	364	9.88e-24	103
k141_542755_14	NCBI|WP_063856745.1|1|1|vanS-L|vanS-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-L|AMR|glycopeptide	25.5	259	996	364	9.88e-24	103
k141_542755_14	NCBI|WP_222891058.1|1|1|vanS-P|vanS-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-P|AMR|glycopeptide	24.1	290	996	359	3.01e-18	86.7
k141_542755_14	CARD|gb|ADM92605.1|ARO:3000553|adeR	31.6	133	996	247	7.47e-09	56.6
k141_542755_16	CARD|gb|ATC67679.1|ARO:3000838|arlR	32.6	129	565	219	3.52e-12	65.1
k141_542755_16	SARG|ZP_02848503	33.0	115	565	221	6.59e-09	55.5
k141_408007_3	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	31.4	118	202	235	1.14e-12	63.5
k141_408007_3	NCBI|WP_023042613.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	29.4	119	202	232	1.80e-10	57.4
k141_408007_3	NCBI|WP_016295750.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	29.4	119	202	232	1.80e-10	57.4
k141_408007_3	NCBI|WP_063856722.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	30.0	120	202	232	2.47e-10	57.0
k141_408007_3	NCBI|WP_023043165.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	28.6	119	202	232	3.39e-10	56.6
k141_408007_3	NCBI|WP_063856727.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	28.6	119	202	232	4.64e-10	56.2
k141_408007_3	NCBI|WP_063856715.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	28.6	119	202	232	4.64e-10	56.2
k141_408007_3	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	29.7	118	202	233	6.41e-10	55.8
k141_408007_3	CARD|gb|AAD51348.1|ARO:3003066|smeR	31.9	119	202	229	1.67e-07	48.9
k141_43735_45	SARG|YP_002861121	48.1	54	204	212	8.00e-11	58.2
k141_43735_45	NCBI|WP_031281281.1|1|1|catB|catB|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_B_phenicol_O-acetyltransferase|AMR|phenicol	42.4	66	204	210	7.24e-10	55.5
k141_43735_45	SARG|YP_001779894	46.3	54	204	212	7.40e-10	55.5
k141_43735_45	SARG|YP_001389621	44.4	54	204	212	1.91e-09	54.3
k141_43735_45	SARG|U19459.gene.p01	42.4	59	204	212	3.59e-09	53.5
k141_43735_45	SARG|YP_001785579	44.4	54	204	212	3.59e-09	53.5
k141_43735_45	SARG|M58472.1.gene1.p01	28.2	131	204	209	1.22e-08	52.0
k141_43735_45	NCBI|KGT34314.1|1|1|catC|catC|acetyltransferase|1|CHLORAMPHENICOL|PHENICOL|type_C_phenicol_O-acetyltransferase|AMR|phenicol	28.6	112	204	219	8.65e-08	49.7
k141_43735_45	SARG|AAS89471	27.0	111	204	210	2.78e-07	48.1
k141_43735_45	NCBI|WP_071766400.1|1|1|catB8|catB8|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_B-3_phenicol_O-acetyltransferase_CatB8|AMR|phenicol	32.4	74	204	210	2.78e-07	48.1
k141_43735_46	megares|MEG_7070|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TETD_1	34.0	100	297	138	6.99e-15	69.3
k141_908284_1	NCBI|CZR78671.1|1|1|vanT-Cd|vanT-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-Cd|AMR|glycopeptide	35.1	194	202	712	2.21e-31	119
k141_908284_3	SARG|gb|AML99881.1|ARO:3001327|mdtK	25.7	447	449	474	4.57e-31	123
k141_792937_1	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	43.6	319	414	346	8.60e-84	259
k141_792937_25	CARD|gb|ADM92605.1|ARO:3000553|adeR	35.7	126	241	247	3.09e-14	68.9
k141_792937_25	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	34.9	129	241	232	1.73e-13	66.6
k141_792937_25	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	35.2	125	241	232	4.48e-13	65.5
k141_792937_25	CARD|gb|ATC67679.1|ARO:3000838|arlR	33.6	107	241	219	9.04e-12	61.6
k141_792937_25	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	32.4	105	241	229	1.91e-11	60.8
k141_792937_25	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	35.5	107	241	235	3.82e-11	60.1
k141_792937_25	NCBI|WP_063856727.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	37.0	108	241	232	9.44e-11	58.9
k141_792937_25	NCBI|WP_023042613.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	37.0	108	241	232	9.44e-11	58.9
k141_792937_25	NCBI|WP_016295750.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	37.0	108	241	232	9.44e-11	58.9
k141_792937_25	NCBI|WP_063856715.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	37.0	108	241	232	9.44e-11	58.9
k141_390033_7	SARG|ZP_04606269	32.9	152	303	299	5.67e-10	58.2
k141_101909_4	SARG|gb|AAV85982.1|ARO:3000535|macB	31.4	236	265	644	2.31e-24	100
k141_101909_4	SARG|gi|696368937|ref|WP_032943949.1|	28.4	232	265	648	3.81e-20	88.6
k141_101909_4	SARG|gi|851913025|ref|WP_048215946.1|	28.4	232	265	648	3.81e-20	88.6
k141_101909_4	SARG|gi|489930965|ref|WP_003834285.1|	28.4	232	265	648	3.81e-20	88.6
k141_101909_4	SARG|gi|696361545|ref|WP_032936694.1|	28.4	232	265	648	5.16e-20	88.2
k141_101909_4	SARG|gi|489936909|ref|WP_003840216.1|	28.4	232	265	648	5.16e-20	88.2
k141_101909_4	SARG|gi|507079862|ref|WP_016150620.1|	28.4	232	265	648	5.16e-20	88.2
k141_101909_4	SARG|gi|949791377|ref|WP_057104572.1|	28.4	232	265	648	5.16e-20	88.2
k141_101909_4	SARG|gi|495067432|ref|WP_007792257.1|	29.1	237	265	647	6.98e-20	87.8
k141_101909_4	SARG|gi|494938585|ref|WP_007664615.1|	29.4	245	265	647	6.98e-20	87.8
k141_313154_8	NCBI|WP_005812825.1|1|1|nimJ|nimJ|nitroimidazole_reductase|2|NITROIMIDAZOLE|NITROIMIDAZOLE|5-nitroimidazole_reductase_NimJ|AMR|nitroimidazole	42.5	153	159	165	3.08e-39	129
k141_313154_8	NCBI|WP_087312253.1|1|1|nimG|nimG||2|NITROIMIDAZOLE|NITROIMIDAZOLE|5-nitroimidazole_reductase_NimG|AMR|nitroimidazole	42.6	162	159	164	1.20e-38	128
k141_313154_8	megares|MEG_4193|Drugs|Metronidazole|nim_nitroimidazole_reductase|NIMI_1	44.8	154	159	152	2.76e-37	124
k141_313154_8	ResF|nimI_1_FJ940887_1	44.8	154	159	165	4.01e-37	124
k141_313154_8	megares|MEG_4192|Drugs|Metronidazole|nim_nitroimidazole_reductase|NIMI_1	44.2	154	159	154	4.14e-37	124
k141_313154_8	megares|MEG_4190|Drugs|Metronidazole|nim_nitroimidazole_reductase|NIMI_1	44.2	154	159	152	5.53e-37	123
k141_313154_8	megares|MEG_4191|Drugs|Metronidazole|nim_nitroimidazole_reductase|NIMI_1	44.8	154	159	152	5.53e-37	123
k141_313154_8	ResF|nimI_1_FJ940889_1	44.2	154	159	165	5.68e-37	124
k141_313154_8	NCBI|WP_005812773.1|1|1|nimE|nimE|nitroimidazole_reductase|2|NITROIMIDAZOLE|NITROIMIDAZOLE|5-nitroimidazole_reductase_NimE|AMR|nitroimidazole	43.2	162	159	170	6.55e-37	124
k141_313154_8	NCBI|WP_032488596.1|1|1|nimA|nimA|nitroimidazole_reductase|2|NITROIMIDAZOLE|NITROIMIDAZOLE|5-nitroimidazole_reductase_NimA|AMR|nitroimidazole	40.5	153	159	176	7.76e-37	124
k141_313154_11	SARG|gi|917229923|ref|WP_051836635.1|	33.1	532	584	620	8.39e-76	251
k141_313154_11	SARG|gi|921231571|ref|WP_053176464.1|	32.1	529	584	620	1.21e-74	248
k141_313154_11	SARG|gi|917172177|ref|WP_051778889.1|	32.1	529	584	620	1.68e-74	248
k141_313154_11	SARG|gi|860594225|ref|WP_048475168.1|	32.0	535	584	620	1.68e-74	248
k141_313154_11	SARG|gi|926294973|ref|WP_053631154.1|	31.6	531	584	620	1.68e-74	248
k141_313154_11	SARG|gi|772774655|ref|WP_045322518.1|	32.3	529	584	620	1.68e-74	248
k141_313154_11	SARG|gi|919568551|ref|WP_052871170.1|	32.5	530	584	620	2.35e-74	248
k141_313154_11	SARG|gi|926356413|ref|WP_053687351.1|	31.6	531	584	620	2.35e-74	248
k141_313154_11	SARG|gi|496018010|ref|WP_008742581.1|	32.5	532	584	623	3.49e-74	247
k141_313154_11	SARG|gi|917203192|ref|WP_051809904.1|	31.8	529	584	620	6.38e-74	246
k141_313154_12	SARG|gi|558888514|ref|WP_023543283.1|	31.4	558	580	615	4.54e-78	257
k141_313154_12	SARG|gi|928900436|ref|WP_053931243.1|	33.7	504	580	600	6.32e-78	256
k141_313154_12	SARG|gi|664579989|ref|WP_031094015.1|	33.7	504	580	601	6.46e-78	256
k141_313154_12	SARG|gi|517347347|ref|WP_018522839.1|	33.3	507	580	601	9.04e-78	256
k141_313154_12	SARG|gi|664556405|ref|WP_031071225.1|	34.1	510	580	602	1.29e-77	256
k141_313154_12	SARG|gi|664180077|ref|WP_030714054.1|	33.8	509	580	605	2.70e-77	255
k141_313154_12	SARG|AF170880.4.gene1.p01	31.0	575	580	615	3.37e-77	255
k141_313154_12	SARG|gi|662175949|ref|WP_030118884.1|	34.4	509	580	605	3.77e-77	254
k141_313154_12	SARG|gi|1045390184|ref|WP_065479071.1|	32.1	560	580	605	3.77e-77	254
k141_313154_12	SARG|gi|764446018|ref|WP_044369325.1|	34.0	509	580	605	5.27e-77	254
k141_236309_4	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	23.2	487	488	1024	1.02e-35	140
k141_236309_4	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	23.2	487	488	1024	1.02e-35	140
k141_236309_4	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	23.2	487	488	1024	1.02e-35	140
k141_236309_4	SARG|gb|CAA53189|ARO:3000521|mupA	23.2	487	488	1024	1.02e-35	140
k141_333063_1	SARG|gb|AAG05915.1|ARO:3004074|MuxB	28.6	651	674	1043	6.76e-67	236
k141_333063_1	SARG|gb|CAH14033.1|ARO:3004100|LpeB	26.8	661	674	1014	9.02e-66	233
k141_333063_1	CARD|gb|AAC75137.1|ARO:3000794|mdtC	29.0	527	674	1025	3.70e-58	211
k141_333063_1	SARG|gi|1011247976|ref|WP_062166935.1|	26.6	598	674	1048	1.84e-57	209
k141_333063_1	SARG|gi|951150103|ref|WP_057630678.1|	26.6	598	674	1048	4.53e-57	208
k141_333063_1	SARG|gi|938782788|ref|WP_054658106.1|	26.6	598	674	1047	9.12e-56	204
k141_333063_1	SARG|gb|AAG05914|ARO:3004075|MuxC	26.0	684	674	1036	1.19e-55	204
k141_333063_1	SARG|CAC14595	25.8	597	674	1040	2.96e-55	202
k141_333063_1	SARG|CAG34257	25.6	597	674	1040	2.96e-55	202
k141_333063_1	SARG|gi|951155204|ref|WP_057635531.1|	26.0	597	674	1047	5.51e-55	202
k141_333063_2	SARG|gi|740519593|ref|WP_038347927.1|	24.3	189	335	406	6.02e-10	58.9
k141_333063_2	SARG|gi|445932788|ref|WP_000010643.1|	24.3	189	335	406	8.04e-10	58.5
k141_179389_8	SARG|YP_608682	27.1	325	360	1042	2.70e-38	144
k141_179389_8	SARG|YP_001668663	27.6	315	360	1043	2.25e-37	142
k141_179389_8	SARG|gi|852273548|ref|WP_048328542.1|	29.1	320	360	1043	7.57e-37	140
k141_179389_8	SARG|gi|510946471|ref|WP_016264177.1|	28.9	322	360	1043	1.39e-36	139
k141_179389_8	SARG|gi|730504935|ref|WP_034031531.1|	28.9	322	360	1043	1.39e-36	139
k141_179389_8	SARG|U57969.gene.p01	28.6	322	360	1043	2.54e-36	139
k141_179389_8	SARG|gi|489253397|ref|WP_003161410.1|	28.6	322	360	1043	2.54e-36	139
k141_179389_8	SARG|NC_002516.2.881071.p01	28.6	322	360	1043	2.54e-36	139
k141_179389_8	SARG|gi|757680562|ref|WP_042911120.1|	28.6	322	360	1043	4.65e-36	138
k141_179389_8	SARG|gi|686100357|ref|WP_031756979.1|	28.3	322	360	1043	4.65e-36	138
k141_275666_4	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	32.7	104	399	228	4.75e-08	52.4
k141_83837_2	SARG|ZP_02952732	25.7	451	603	652	3.47e-29	121
k141_83837_2	SARG|L20800.gene.p01	25.5	451	603	652	3.47e-29	121
k141_83837_2	SARG|ZP_02632674	25.7	451	603	660	3.58e-29	121
k141_83837_2	SARG|NP_348076	24.9	445	603	652	1.47e-28	119
k141_83837_2	SARG|YP_002850805	25.3	451	603	652	2.61e-28	119
k141_83837_2	SARG|CAA37477	33.5	203	603	663	3.92e-21	96.7
k141_83837_2	SARG|L42544.gene.p01	22.1	443	603	651	5.07e-21	96.3
k141_83837_2	SARG|AAV80410	22.1	443	603	651	2.07e-20	94.4
k141_83837_2	SARG|AAT02170	35.7	154	603	644	2.42e-18	87.8
k141_83837_2	SARG|ACA42497	35.7	154	603	646	2.43e-18	87.8
k141_544729_2	ResF|mre(A)_1_U92073_1	27.5	178	275	310	3.28e-13	67.4
k141_544729_2	SARG|gb|AAB64408.1|ARO:3007050|mreA	27.5	178	275	311	3.30e-13	67.4
k141_122054_2	SARG|gb|BAE85481.1|ARO:3003727|vanKI	38.0	187	386	375	4.29e-33	126
k141_122054_2	megares|MEG_7563|Drugs|Glycopeptide|VanB-type_resistance_protein|VANXB_3	37.2	183	386	409	3.71e-32	124
k141_7494_8	CARD|gb|AAK37618.1|ARO:3005008|TxR	37.9	314	511	318	3.20e-58	194
k141_852564_1	megares|MEG_5409|Drugs|beta-lactam|Penicillin_binding_protein|PBP4B_1	35.0	449	636	434	1.42e-83	268
k141_852564_2	SARG|gi|948137056|ref|WP_056795395.1|	36.0	544	579	602	2.83e-97	307
k141_852564_2	SARG|gi|664458452|ref|WP_030980047.1|	36.2	544	579	601	2.28e-95	302
k141_852564_2	SARG|gi|497748188|ref|WP_010062372.1|	35.3	547	579	605	7.01e-95	301
k141_852564_2	SARG|gi|496018010|ref|WP_008742581.1|	35.3	564	579	623	1.11e-94	301
k141_852564_2	SARG|gi|664395661|ref|WP_030922045.1|	35.7	544	579	601	3.45e-94	299
k141_852564_2	SARG|gi|663330365|ref|WP_030329892.1|	35.1	552	579	607	5.65e-94	299
k141_852564_2	SARG|gi|951183771|ref|WP_057661487.1|	35.0	552	579	603	7.16e-94	298
k141_852564_2	SARG|gi|664180077|ref|WP_030714054.1|	35.1	547	579	605	7.54e-94	298
k141_852564_2	SARG|gi|948040364|ref|WP_056699531.1|	35.1	552	579	603	1.01e-93	298
k141_852564_2	SARG|gi|695891735|ref|WP_032792824.1|	35.0	552	579	603	1.41e-93	298
k141_852934_1	SARG|NP_348076	30.8	458	463	652	1.83e-64	218
k141_852934_1	SARG|YP_002850805	29.8	457	463	652	1.35e-61	211
k141_852934_1	SARG|AAV80410	31.1	456	463	651	6.84e-60	206
k141_852934_1	SARG|L20800.gene.p01	29.1	457	463	652	1.34e-59	205
k141_852934_1	SARG|ZP_02952732	29.1	457	463	652	1.86e-59	205
k141_852934_1	SARG|ZP_02632674	29.1	457	463	660	2.11e-59	205
k141_852934_1	SARG|FN594949.1.gene24.p01	30.4	460	463	640	4.11e-59	204
k141_852934_1	NCBI|WP_003454408.1|1|1|tet(44)|tet(44)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(44)|AMR|tetracycline	30.9	457	463	640	4.11e-59	204
k141_852934_1	SARG|L42544.gene.p01	30.9	456	463	651	9.42e-59	203
k141_852934_1	SARG|ABV82118	30.5	455	463	639	2.90e-58	201
k141_872389_2	SARG|ARX76269.1	21.4	173	218	619	7.13e-07	48.1
k141_622783_5	SARG|gi|504542119|ref|WP_014729221.1|	40.6	219	227	647	5.66e-50	171
k141_622783_5	SARG|YP_001438541	40.2	219	227	647	2.91e-49	169
k141_622783_5	SARG|gi|938461734|ref|WP_054625806.1|	40.2	219	227	647	2.91e-49	169
k141_622783_5	SARG|gi|938460528|ref|WP_054624864.1|	40.2	219	227	647	2.91e-49	169
k141_622783_5	SARG|gi|1020141879|ref|WP_063264839.1|	40.2	219	227	647	2.91e-49	169
k141_622783_5	SARG|gi|490522515|ref|WP_004387938.1|	40.2	219	227	647	2.91e-49	169
k141_622783_5	SARG|gi|696402390|ref|WP_032974230.1|	40.2	219	227	647	5.59e-49	168
k141_622783_5	SARG|gi|696423952|ref|WP_032993748.1|	40.2	219	227	647	5.59e-49	168
k141_622783_5	SARG|gi|655997348|ref|WP_029038923.1|	40.2	219	227	647	7.75e-49	168
k141_622783_5	SARG|gi|426326769|emb|CCK10228.1|	40.2	219	227	648	7.83e-49	168
k141_431006_10	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	31.2	77	355	231	6.20e-06	45.8
k141_239330_10	SARG|gi|803568669|ref|WP_046077412.1|	24.9	241	272	648	1.21e-15	75.5
k141_239330_10	SARG|gi|446110352|ref|WP_000188207.1|	24.9	241	272	648	1.21e-15	75.5
k141_239330_10	SARG|YP_002382193	24.9	241	272	648	1.21e-15	75.5
k141_239330_10	SARG|gi|803575554|ref|WP_046081557.1|	24.9	241	272	648	1.21e-15	75.5
k141_239330_10	SARG|gi|446110351|ref|WP_000188206.1|	24.9	241	272	648	1.21e-15	75.5
k141_239330_10	SARG|gi|736472622|ref|WP_034494292.1|	23.9	209	272	648	2.74e-12	65.5
k141_239330_10	SARG|gi|1035717981|ref|WP_064557480.1|	23.4	209	272	648	6.65e-12	64.3
k141_239330_10	SARG|gi|1035706844|ref|WP_064548272.1|	25.2	210	272	648	2.16e-11	62.8
k141_239330_10	SARG|gi|1035670474|ref|WP_064517458.1|	23.3	206	272	648	2.90e-11	62.4
k141_354882_2	SARG|gi|446026113|ref|WP_000103968.1|	36.7	199	263	306	1.28e-34	125
k141_354882_2	SARG|gi|507044560|ref|WP_016115614.1|	36.2	199	263	306	1.89e-33	122
k141_354882_2	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	34.2	222	263	343	1.08e-31	118
k141_373350_15	CARD|gb|WKR28567.1|ARO:3007678|IreK	32.9	252	534	718	6.01e-34	135
k141_220830_4	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.6	518	604	655	8.04e-67	229
k141_220830_4	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.4	518	604	655	1.12e-66	228
k141_220830_4	SARG|gb|AKA86814|ARO:3003746|optrA	28.4	518	604	655	1.12e-66	228
k141_220830_4	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.4	518	604	655	1.55e-66	228
k141_220830_4	megares|MEG_4322|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.9	506	604	655	1.55e-66	228
k141_220830_4	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.4	518	604	655	2.15e-66	228
k141_220830_4	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.6	518	604	655	2.15e-66	228
k141_220830_4	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.4	518	604	655	2.98e-66	227
k141_220830_4	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.4	518	604	655	2.98e-66	227
k141_220830_4	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.4	518	604	655	2.98e-66	227
k141_298427_4	NCBI|WP_005480402.1|1|1|tet(35)|tet(35)|efflux|2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_Na+/H+_antiporter_family_transporter_Tet(35)|AMR|tetracycline	37.6	529	518	533	1.77e-96	301
k141_298427_4	SARG|AF353562.gene.p01	34.9	372	518	369	3.65e-49	172
k141_48304_2	SARG|P42332	28.9	218	513	306	2.59e-13	69.7
k141_48304_2	SARG|ABB80128	28.9	218	513	306	2.59e-13	69.7
k141_48304_2	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	28.9	218	513	306	2.59e-13	69.7
k141_48304_2	SARG|gi|510143239|gb|AGN36970.1|	28.9	218	513	313	2.77e-13	69.7
k141_48304_2	SARG|gi|542061059|gb|ERI11611.1|	28.6	217	513	316	5.11e-13	68.9
k141_48304_2	SARG|AAD21213	28.4	218	513	306	1.51e-12	67.4
k141_48304_2	SARG|gi|445996723|ref|WP_000074578.1|	31.2	218	513	309	2.78e-12	66.6
k141_48304_2	SARG|gi|445996722|ref|WP_000074577.1|	30.7	218	513	309	3.73e-12	66.2
k141_48304_2	SARG|gi|445996719|ref|WP_000074574.1|	29.6	213	513	309	4.99e-12	65.9
k141_48304_2	SARG|gi|1043490477|ref|WP_065382463.1|	30.7	218	513	309	6.69e-12	65.5
k141_663379_3	NCBI|ACF30254.1|1|1|mtrR|mtrR|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_system_transcriptional_repressor_MtrR|AMR|efflux	35.4	65	415	210	3.61e-06	46.6
k141_663379_3	NCBI|CAA81047.1|1|1|mtrR|mtrR|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_system_transcriptional_repressor_MtrR|AMR|efflux	35.4	65	415	210	3.61e-06	46.6
k141_87555_5	SARG|M35190.gene.p01	38.5	205	219	207	7.46e-44	145
k141_87555_5	NCBI|WP_043774378.1|1|1|catA13|catA13|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_A-13_phenicol_O-acetyltransferase|AMR|phenicol	37.6	205	219	207	2.98e-43	143
k141_87555_5	SARG|YP_001144149	37.6	205	219	208	3.06e-43	143
k141_87555_5	SARG|gb|APB03217.1|ARO:3003983|CatU	35.4	206	219	217	1.25e-41	139
k141_87555_5	SARG|YP_001310303	33.7	205	219	219	7.41e-41	137
k141_87555_5	NCBI|WP_063843221.1|1|1|catA16|catA16|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_A-16_phenicol_O-acetyltransferase_CatQ|AMR|phenicol	33.0	215	219	219	1.05e-40	137
k141_87555_5	SARG|M55620.gene.p01	33.2	205	219	219	5.87e-40	135
k141_87555_5	SARG|S48276.1.gene1.p01	34.4	209	219	216	4.28e-39	133
k141_87555_5	SARG|gb|ATL63235.1|ARO:3004357|catV	32.7	208	219	219	1.84e-38	131
k141_87555_5	SARG|M93113.gene.p01	32.2	205	219	219	5.17e-38	130
k141_433229_3	megares|MEG_5400|Drugs|beta-lactam|Penicillin_binding_protein|PBP2_1	31.6	566	621	633	3.37e-79	262
k141_433229_3	megares|MEG_3794|Drugs|beta-lactam|Penicillin_binding_protein|MECA_1	28.5	512	621	668	1.16e-45	171
k141_433229_3	SARG|gi|1028095738|ref|WP_063852626.1|	28.5	512	621	668	1.16e-45	171
k141_433229_3	megares|MEG_3793|Drugs|beta-lactam|Penicillin_binding_protein|MECA_1	28.7	512	621	668	1.57e-45	170
k141_433229_3	SARG|gi|1028095782|ref|WP_063852670.1|	28.7	512	621	668	2.14e-45	170
k141_433229_3	SARG|gi|1028095795|ref|WP_063852683.1|	28.7	512	621	668	2.14e-45	170
k141_433229_3	SARG|CAA73547	28.5	512	621	668	2.92e-45	169
k141_433229_3	SARG|KC243783.1.gene1.p01	28.5	512	621	668	2.92e-45	169
k141_433229_3	SARG|gi|686116460|ref|WP_031766030.1|	28.5	512	621	668	2.92e-45	169
k141_433229_3	SARG|gi|686149752|ref|WP_031783696.1|	28.7	512	621	668	2.92e-45	169
k141_759877_13	SARG|ZP_04220669	50.0	60	190	265	9.98e-11	58.2
k141_759877_13	SARG|ZP_04210257	50.0	60	190	265	9.98e-11	58.2
k141_759877_13	SARG|ZP_04271500	50.0	60	190	265	9.98e-11	58.2
k141_759877_13	SARG|YP_294981	43.3	67	190	293	2.96e-10	57.0
k141_759877_13	SARG|ZP_01438526	36.2	69	190	306	4.23e-10	56.6
k141_759877_13	SARG|ZP_04637931	38.0	71	190	269	6.65e-10	55.8
k141_759877_13	SARG|YP_001178170	39.4	71	190	273	6.80e-10	55.8
k141_759877_13	SARG|Q5P6K4	42.2	64	190	274	6.84e-10	55.8
k141_759877_13	SARG|YP_001268143	47.9	71	190	276	6.91e-10	55.8
k141_759877_13	SARG|YP_001749617	49.2	63	190	276	6.91e-10	55.8
k141_11833_9	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	30.7	404	688	703	1.45e-39	154
k141_875067_1	SARG|gi|507055561|ref|WP_016126482.1|	34.1	226	351	309	1.13e-27	109
k141_875067_1	SARG|gi|507050365|ref|WP_016121371.1|	34.1	226	351	309	3.00e-27	108
k141_875067_1	SARG|gi|488053456|ref|WP_002124853.1|	34.1	226	351	309	3.00e-27	108
k141_875067_1	SARG|gi|488067981|ref|WP_002139378.1|	33.6	226	351	309	7.94e-27	107
k141_875067_1	SARG|gi|447057509|ref|WP_001134765.1|	33.6	226	351	309	1.52e-26	106
k141_875067_1	SARG|gi|488130770|ref|WP_002201978.1|	33.2	226	351	309	2.10e-26	105
k141_875067_1	SARG|gi|487936534|ref|WP_002010000.1|	34.1	211	351	309	2.10e-26	105
k141_875067_1	SARG|gi|507023808|ref|WP_016095885.1|	33.2	226	351	309	2.90e-26	105
k141_875067_1	SARG|gi|447057510|ref|WP_001134766.1|	33.2	226	351	309	2.90e-26	105
k141_875067_1	SARG|gi|488068784|ref|WP_002140181.1|	33.2	226	351	309	4.00e-26	105
k141_126029_1	SARG|gi|921231571|ref|WP_053176464.1|	34.6	557	715	620	1.98e-67	232
k141_126029_1	SARG|gi|917172177|ref|WP_051778889.1|	34.6	557	715	620	2.74e-67	232
k141_126029_1	SARG|gi|496018010|ref|WP_008742581.1|	34.1	557	715	623	2.91e-67	232
k141_126029_1	SARG|gi|919568551|ref|WP_052871170.1|	34.6	557	715	620	7.28e-67	231
k141_126029_1	SARG|gi|772774655|ref|WP_045322518.1|	34.3	562	715	620	1.93e-66	229
k141_126029_1	SARG|gi|799286378|ref|WP_045936958.1|	34.0	561	715	620	2.67e-66	229
k141_126029_1	SARG|gi|917127754|ref|WP_051734466.1|	34.0	561	715	620	2.67e-66	229
k141_126029_1	SARG|gi|926294973|ref|WP_053631154.1|	34.0	561	715	620	2.67e-66	229
k141_126029_1	SARG|gi|926356413|ref|WP_053687351.1|	34.0	561	715	620	3.69e-66	229
k141_126029_1	SARG|gi|926345639|ref|WP_053677539.1|	34.0	561	715	620	3.69e-66	229
k141_126029_2	SARG|gb|AAC74000.1|ARO:3003950|msbA	27.9	494	895	582	4.85e-43	164
k141_126029_2	SARG|gi|917203192|ref|WP_051809904.1|	29.3	570	895	620	1.50e-41	160
k141_126029_2	SARG|gi|772774655|ref|WP_045322518.1|	28.7	567	895	620	1.50e-41	160
k141_126029_2	SARG|gi|926351744|ref|WP_053683383.1|	29.4	568	895	648	1.51e-41	161
k141_126029_2	SARG|gi|926376632|ref|WP_053705806.1|	29.1	570	895	620	2.70e-41	160
k141_126029_2	SARG|gi|917229923|ref|WP_051836635.1|	29.0	566	895	620	8.73e-41	158
k141_126029_2	SARG|gi|926356413|ref|WP_053687351.1|	28.9	570	895	620	8.73e-41	158
k141_126029_2	SARG|gi|926345639|ref|WP_053677539.1|	28.9	570	895	620	8.73e-41	158
k141_126029_2	SARG|gi|799286378|ref|WP_045936958.1|	28.9	570	895	620	8.73e-41	158
k141_126029_2	SARG|gi|917127754|ref|WP_051734466.1|	28.9	570	895	620	8.73e-41	158
k141_837261_22	NCBI|WP_011116970.1|1|1|tetAB_B|tetAB_B|efflux|2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_TetAB_subunit_B|AMR|tetracycline	24.3	206	248	528	8.77e-10	57.4
k141_837261_28	SARG|gi|494215524|ref|WP_007131565.1|	22.8	425	551	492	6.09e-09	57.4
k141_837261_28	SARG|gi|738272573|ref|WP_036227195.1|	22.8	425	551	492	6.94e-07	50.8
k141_837261_28	SARG|gi|495453058|ref|WP_008177752.1|	21.9	425	551	492	9.16e-07	50.4
k141_837261_28	NCBI|WP_002294513.1|1|1|lsa(E)|lsa(E)|target_protection|2|LINCOSAMIDE/STREPTOGRAMIN|LINCOSAMIDE/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_Lsa(E)|AMR|multidrug	24.0	204	551	494	9.18e-07	50.4
k141_837261_28	SARG|gi|640690880|ref|WP_025115215.1|	22.4	425	551	492	3.68e-06	48.5
k141_837261_28	SARG|gi|738205817|ref|WP_036161732.1|	22.4	428	551	492	4.85e-06	48.1
k141_184397_4	CARD|gb|AAC16242.1|ARO:3005069|rsmA	46.3	54	77	61	6.02e-15	61.6
k141_300747_3	SARG|gb|ANZ79240.1|ARO:3004035|tetA(60)	30.8	224	397	579	7.40e-18	84.3
k141_300747_3	NCBI|WP_289811734.1|1|1|tetA(60)|tetA(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_A|AMR|tetracycline	30.6	222	397	579	1.32e-17	83.6
k141_300747_3	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	30.6	209	397	574	5.51e-13	69.3
k141_69437_3	SARG|gi|1002393246|ref|WP_061378420.1|	27.7	231	305	660	3.83e-19	86.7
k141_69437_3	SARG|gi|1002399350|ref|WP_061382108.1|	32.0	169	305	660	6.95e-19	85.9
k141_69437_3	SARG|gi|554961629|ref|WP_023206204.1|	27.3	231	305	660	1.70e-18	84.7
k141_69437_3	SARG|gi|920043689|ref|WP_052939451.1|	27.3	231	305	660	2.29e-18	84.3
k141_69437_3	SARG|YP_002850217	32.0	169	305	660	2.29e-18	84.3
k141_69437_3	SARG|gi|746476198|ref|WP_039514283.1|	27.3	231	305	660	2.29e-18	84.3
k141_69437_3	SARG|gi|446571408|ref|WP_000648754.1|	27.3	231	305	660	2.29e-18	84.3
k141_69437_3	SARG|gi|446571426|ref|WP_000648772.1|	27.3	231	305	660	2.29e-18	84.3
k141_69437_3	SARG|gi|1002387632|ref|WP_061375456.1|	27.3	231	305	660	2.29e-18	84.3
k141_69437_3	SARG|gi|446571414|ref|WP_000648760.1|	27.3	231	305	660	2.29e-18	84.3
k141_376428_5	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	28.0	239	230	307	4.05e-16	74.7
k141_376428_5	NCBI|WP_002294513.1|1|1|lsa(E)|lsa(E)|target_protection|2|LINCOSAMIDE/STREPTOGRAMIN|LINCOSAMIDE/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_Lsa(E)|AMR|multidrug	25.5	208	230	494	1.55e-15	73.9
k141_376428_5	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.3	230	230	655	2.41e-12	64.7
k141_376428_5	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.3	230	230	655	2.41e-12	64.7
k141_376428_5	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.3	230	230	655	2.41e-12	64.7
k141_376428_5	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.3	230	230	655	2.41e-12	64.7
k141_376428_5	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.3	230	230	655	2.41e-12	64.7
k141_376428_5	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.3	230	230	655	2.41e-12	64.7
k141_376428_5	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.3	230	230	655	2.41e-12	64.7
k141_376428_5	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.3	230	230	655	2.41e-12	64.7
k141_108901_3	CARD|gb|BAD59497.1|ARO:3000501|rpoB2	47.1	1194	1157	1162	0.0	1036
k141_108901_3	CARD|gb|WP_041777404.1|ARO:3004480|Bado_rpoB_RIF	46.3	1211	1157	1186	0.0	1017
k141_108901_3	megares|MEG_8674|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB_1	46.3	1211	1157	1186	0.0	1017
k141_244113_1	NCBI|CZR78671.1|1|1|vanT-Cd|vanT-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-Cd|AMR|glycopeptide	42.6	176	178	712	3.37e-39	140
k141_244113_1	SARG|gb|ABA71733.1|ARO:3002972|vanTG	43.4	173	178	712	2.23e-38	137
k141_244113_1	NCBI|WP_063856752.1|1|1|vanT-G|vanT-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-G|AMR|glycopeptide	41.6	173	178	711	1.45e-34	127
k141_244113_1	SARG|gb|ABX54690.1|ARO:3002974|vanTrL	39.3	173	178	366	3.15e-34	122
k141_244113_1	NCBI|WP_063856756.1|1|1|vanT-C|vanT-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-C|AMR|glycopeptide	43.3	171	178	700	1.73e-33	124
k141_244113_1	NCBI|WP_063856755.1|1|1|vanT-C|vanT-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-C|AMR|glycopeptide	42.7	171	178	700	1.73e-33	124
k141_244113_1	NCBI|WP_063856759.1|1|1|vanTc3|vanTc3|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT|AMR|glycopeptide	42.1	171	178	700	1.12e-32	121
k141_244113_1	megares|MEG_7535|Drugs|Glycopeptide|VanN-type_resistance_protein|VANTN_1	39.4	160	178	656	3.63e-32	120
k141_244113_1	SARG|JF802084.2.gene3.p01	39.4	160	178	700	3.90e-32	120
k141_244113_1	SARG|AF162694.1.gene4.p01	41.2	170	178	698	1.35e-31	118
k141_244113_7	SARG|gb|ADZ12699.1|ARO:3005091|RanA	27.3	227	248	258	2.64e-18	80.5
k141_244113_7	SARG|gb|AAK76137.1|ARO:3000024|patA	23.7	228	248	564	1.13e-10	60.1
k141_896364_2	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	37.6	237	248	255	5.84e-48	158
k141_896364_2	CARD|gb|BAB80490.1|ARO:3007644|Cper_cplR	34.2	79	248	568	1.34e-07	50.8
k141_896364_2	NCBI|AKC61310.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	32.9	79	248	552	5.74e-07	48.9
k141_896364_2	NCBI|AJP12342.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	31.3	99	248	550	2.46e-06	47.0
k141_628303_1	SARG|gi|502669352|ref|WP_012905216.1|	29.8	208	204	648	2.05e-16	75.9
k141_628303_1	SARG|gi|803568669|ref|WP_046077412.1|	29.3	208	204	648	3.19e-15	72.4
k141_628303_1	SARG|gi|446110352|ref|WP_000188207.1|	29.3	208	204	648	3.19e-15	72.4
k141_628303_1	SARG|YP_002382193	29.3	208	204	648	3.19e-15	72.4
k141_628303_1	SARG|gi|803575554|ref|WP_046081557.1|	29.3	208	204	648	3.19e-15	72.4
k141_628303_1	SARG|gi|446110351|ref|WP_000188206.1|	29.3	208	204	648	3.19e-15	72.4
k141_628303_1	SARG|gi|1035706844|ref|WP_064548272.1|	27.9	208	204	648	1.66e-13	67.4
k141_628303_1	SARG|gi|1035670474|ref|WP_064517458.1|	27.4	208	204	648	2.25e-13	67.0
k141_628303_1	SARG|gi|1035717981|ref|WP_064557480.1|	27.4	208	204	648	2.25e-13	67.0
k141_628303_1	SARG|gi|736472622|ref|WP_034494292.1|	26.9	208	204	648	7.59e-13	65.5
k141_916334_24	CARD|gb|AAN28945.1|ARO:3003785|Ctra_murA_FOF	32.2	441	427	444	2.07e-57	194
k141_916334_29	SARG|gb|APB03219.1|ARO:3003986|TaeA	37.2	653	653	648	6.52e-140	422
k141_916334_29	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.8	519	653	655	2.35e-69	237
k141_916334_29	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.9	526	653	655	1.21e-68	235
k141_916334_29	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.6	519	653	655	3.22e-68	234
k141_916334_29	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.9	526	653	655	3.22e-68	234
k141_916334_29	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.9	526	653	655	6.19e-68	233
k141_916334_29	SARG|gb|AKA86814|ARO:3003746|optrA	31.9	526	653	655	6.19e-68	233
k141_916334_29	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.7	526	653	655	8.58e-68	233
k141_916334_29	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.7	526	653	655	8.58e-68	233
k141_916334_29	megares|MEG_4322|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.1	523	653	655	1.19e-67	232
k141_34453_1	megares|MEG_7563|Drugs|Glycopeptide|VanB-type_resistance_protein|VANXB_2	32.7	462	456	451	3.95e-62	207
k141_34453_1	megares|MEG_7572|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	31.8	456	456	481	6.48e-59	199
k141_34453_1	megares|MEG_7571|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	30.5	465	456	451	9.44e-58	196
k141_341133_5	SARG|gb|AAK76137.1|ARO:3000024|patA	29.8	225	253	564	2.89e-17	79.7
k141_532452_3	CARD|gb|AAK37618.1|ARO:3005008|TxR	39.9	301	453	318	1.99e-64	209
k141_474731_17	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	31.6	231	235	231	1.48e-38	132
k141_474731_17	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	31.6	231	235	231	1.48e-38	132
k141_474731_17	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	31.6	231	235	231	6.44e-37	128
k141_474731_17	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	31.6	231	235	231	1.28e-36	127
k141_474731_17	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	31.6	231	235	231	1.80e-36	127
k141_474731_17	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	30.6	229	235	228	3.30e-36	126
k141_474731_17	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	30.5	226	235	225	2.59e-25	98.2
k141_474731_17	NCBI|XSG12259.1|1|1|drcR|drcR||1|||daptomycin_efflux_response_regulator_transcription_factor_DrcR|AMR|peptide	29.1	223	235	223	2.03e-22	90.5
k141_474731_17	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	29.6	233	235	252	2.54e-22	90.9
k141_474731_17	CARD|gb|AAD51348.1|ARO:3003066|smeR	28.0	225	235	229	1.24e-20	85.9
k141_455471_2	SARG|gi|447195836|ref|WP_001273092.1|	32.5	228	258	306	4.51e-33	121
k141_455471_2	SARG|gi|542061059|gb|ERI11611.1|	32.3	232	258	316	5.51e-33	121
k141_455471_2	SARG|ZP_04081918	32.5	228	258	306	6.31e-33	120
k141_455471_2	SARG|gi|447195835|ref|WP_001273091.1|	32.0	228	258	306	1.24e-32	120
k141_455471_2	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	33.0	215	258	343	3.58e-31	117
k141_455471_2	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	32.3	223	258	307	5.21e-30	113
k141_455471_2	NCBI|QHA94808.1|1|1|narA|narA||1|MADURAMICIN/NARASIN/SALINOMYCIN|IONOPHORE|ionophore_ABC_transporter_ATP-binding_subunit_NarA|AMR|ionophore	30.9	262	258	293	8.04e-29	109
k141_455471_2	SARG|gb|AAA26793|ARO:3003748|oleC	27.5	236	258	325	2.02e-26	103
k141_455471_2	megares|MEG_4276|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|OLEC_1	27.5	236	258	325	2.02e-26	103
k141_455471_2	megares|MEG_2670|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|DRRA_1	29.0	207	258	293	3.00e-20	86.7
k141_455471_5	SARG|gi|983405167|ref|WP_060572706.1|	28.9	232	253	646	9.79e-20	87.0
k141_455471_5	SARG|gi|782756348|ref|WP_045630015.1|	28.9	232	253	646	1.32e-19	86.7
k141_455471_5	SARG|gi|754493745|ref|WP_041910640.1|	28.9	232	253	646	1.79e-19	86.3
k141_455471_5	SARG|gi|694085087|ref|WP_032429904.1|	31.3	224	253	646	1.79e-19	86.3
k141_455471_5	SARG|gi|1032819400|ref|WP_064325534.1|	29.9	231	253	646	1.79e-19	86.3
k141_455471_5	SARG|gi|974588181|ref|WP_059178476.1|	29.0	224	253	646	2.43e-19	85.9
k141_455471_5	SARG|gi|969848384|ref|WP_058609247.1|	29.4	231	253	646	2.43e-19	85.9
k141_455471_5	SARG|YP_001176128	29.0	224	253	646	2.43e-19	85.9
k141_455471_5	SARG|gi|493171912|ref|WP_006174388.1|	29.4	231	253	646	2.43e-19	85.9
k141_455471_5	SARG|gi|644804533|ref|WP_025368306.1|	30.8	224	253	646	3.29e-19	85.5
k141_878480_5	SARG|gb|ABX54690.1|ARO:3002974|vanTrL	31.7	375	387	366	3.81e-49	169
k141_878480_5	SARG|AAY67970	32.8	366	387	698	2.50e-45	164
k141_878480_5	SARG|AF162694.1.gene4.p01	32.8	366	387	698	4.72e-45	164
k141_878480_5	SARG|gi|657686198|ref|WP_029487032.1|	32.8	366	387	698	4.72e-45	164
k141_878480_5	SARG|FJ872411.1.gene43.p01	30.4	372	387	702	1.94e-42	156
k141_878480_5	SARG|gi|498467693|ref|WP_010773049.1|	29.8	373	387	700	1.53e-40	151
k141_878480_5	NCBI|WP_063856756.1|1|1|vanT-C|vanT-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-C|AMR|glycopeptide	30.4	369	387	700	2.61e-37	142
k141_878480_5	SARG|JF802084.2.gene3.p01	29.5	363	387	700	4.84e-37	141
k141_878480_5	NCBI|WP_063856755.1|1|1|vanT-C|vanT-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-C|AMR|glycopeptide	29.5	369	387	700	3.06e-36	139
k141_878480_5	NCBI|WP_063856759.1|1|1|vanTc3|vanTc3|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT|AMR|glycopeptide	28.7	369	387	700	1.02e-33	131
k141_841193_3	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	34.5	232	302	346	1.37e-24	100
k141_917988_2	SARG|Q47748	27.6	279	393	323	3.43e-16	77.8
k141_917988_2	SARG|DQ018711.1.gene4.p01	26.0	265	393	322	6.19e-16	77.0
k141_917988_2	SARG|gb|AAB05626.1|ARO:3002943|vanHB	27.6	279	393	323	6.25e-16	77.0
k141_917988_2	SARG|gb|MBY8651254.1|ARO:3007188|vanH_in_vanP_cl	27.3	183	393	314	2.57e-15	75.1
k141_917988_2	NCBI|WP_063856710.1|1|1|vanH-Pt2|vanH-Pt2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Pt2|AMR|glycopeptide	26.4	296	393	322	3.73e-15	74.7
k141_917988_2	SARG|YP_002333394	31.8	198	393	323	3.76e-15	74.7
k141_917988_2	SARG|gi|738848198|ref|WP_036737307.1|	25.7	265	393	323	5.07e-15	74.3
k141_917988_2	SARG|AF310956.2.gene5.p01	31.3	198	393	323	1.24e-14	73.2
k141_917988_2	NCBI|WP_063856701.1|1|1|vanH-B|vanH-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-B|AMR|glycopeptide	31.3	198	393	323	1.24e-14	73.2
k141_917988_2	SARG|gi|737310392|ref|WP_035293250.1|	25.3	265	393	323	1.67e-14	72.8
k141_264466_9	CARD|gb|BAB41874.1|ARO:3000815|mgrA	35.3	139	151	147	2.97e-25	93.2
k141_207698_5	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	29.5	112	422	229	2.44e-10	59.3
k141_207698_5	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	28.4	109	422	231	8.26e-10	57.8
k141_207698_5	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	28.4	109	422	231	1.50e-09	57.0
k141_207698_5	NCBI|WP_063856725.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	27.5	109	422	231	3.67e-09	55.8
k141_207698_5	NCBI|WP_034872470.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	27.5	109	422	231	4.94e-09	55.5
k141_207698_5	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	26.6	109	422	230	2.32e-07	50.4
k141_207698_5	NCBI|WP_063856722.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	26.7	116	422	232	3.17e-07	50.1
k141_207698_5	NCBI|WP_023043165.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	26.7	116	422	232	1.03e-06	48.5
k141_207698_5	NCBI|WP_023042613.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	25.9	116	422	232	1.03e-06	48.5
k141_207698_5	NCBI|WP_016295750.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	25.9	116	422	232	1.03e-06	48.5
k141_207698_6	CARD|gb|CYF42523.1|ARO:3004047|kdpD	28.5	239	669	885	6.46e-17	84.0
k141_264501_8	SARG|gb|AAK76137.1|ARO:3000024|patA	25.7	214	504	564	4.68e-10	60.8
k141_264501_8	SARG|gb|WP_104671188.1|ARO:3003948|efrA	22.6	274	504	575	3.34e-09	58.2
k141_264501_8	SARG|gi|639148059|ref|WP_024490169.1|	26.9	238	504	602	1.04e-08	56.6
k141_264501_8	SARG|gi|948137056|ref|WP_056795395.1|	26.1	245	504	602	1.38e-08	56.2
k141_264501_8	SARG|gi|754608317|ref|WP_041998010.1|	25.2	254	504	612	2.42e-08	55.5
k141_264501_8	SARG|gi|799286378|ref|WP_045936958.1|	26.9	238	504	620	2.44e-08	55.5
k141_264501_8	SARG|gi|917127754|ref|WP_051734466.1|	26.9	238	504	620	2.44e-08	55.5
k141_264501_8	SARG|gi|926376632|ref|WP_053705806.1|	26.9	238	504	620	2.44e-08	55.5
k141_264501_8	SARG|gi|926294973|ref|WP_053631154.1|	26.9	238	504	620	2.44e-08	55.5
k141_264501_8	SARG|gi|926356413|ref|WP_053687351.1|	26.9	238	504	620	3.22e-08	55.1
k141_227310_1	SARG|gb|AAG05914|ARO:3004075|MuxC	26.8	750	775	1036	4.72e-69	245
k141_227310_1	CARD|gb|AAC75137.1|ARO:3000794|mdtC	25.7	767	775	1025	6.95e-68	241
k141_227310_1	SARG|YP_350221	26.7	763	775	1009	3.35e-66	236
k141_227310_1	SARG|YP_001186705	26.6	767	775	1017	2.58e-64	231
k141_227310_1	SARG|YP_001345921	26.6	772	775	1046	2.17e-62	226
k141_227310_1	SARG|gi|552325898|gb|ERV85344.1|	26.3	772	775	918	2.18e-62	224
k141_227310_1	SARG|gi|347302801|gb|AEO72915.1|	26.3	772	775	1033	1.24e-61	223
k141_227310_1	SARG|gi|504646765|ref|WP_014833867.1|	26.2	772	775	985	1.69e-61	223
k141_227310_1	SARG|CAW25151	26.2	772	775	1046	1.79e-61	223
k141_227310_1	SARG|gb|AAA74437.1|ARO:3000378|MexB	26.2	772	775	1046	2.42e-61	223
k141_92598_7	SARG|AUI09862.1	33.9	271	276	287	1.67e-47	159
k141_92598_7	SARG|gi|1005580705|ref|WP_061671795.1|	28.9	253	276	279	5.24e-23	94.4
k141_783879_3	NCBI|ACF30254.1|1|1|mtrR|mtrR|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_system_transcriptional_repressor_MtrR|AMR|efflux	48.1	54	208	210	1.58e-07	48.9
k141_783879_3	NCBI|CAA81047.1|1|1|mtrR|mtrR|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_system_transcriptional_repressor_MtrR|AMR|efflux	48.1	54	208	210	1.58e-07	48.9
k141_783879_5	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	65.9	44	53	346	1.04e-12	58.9
k141_476829_2	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	29.1	199	729	255	1.67e-19	87.8
k141_476829_2	SARG|gi|696402390|ref|WP_032974230.1|	32.0	259	729	647	6.88e-19	90.1
k141_476829_2	SARG|gi|696423952|ref|WP_032993748.1|	32.0	259	729	647	6.88e-19	90.1
k141_476829_2	SARG|gi|696411918|ref|WP_032982657.1|	31.7	259	729	647	1.20e-18	89.4
k141_476829_2	SARG|gi|495004199|ref|WP_007730213.1|	32.2	236	729	647	1.59e-18	89.0
k141_476829_2	SARG|gi|742409107|ref|WP_038888226.1|	32.2	236	729	647	1.59e-18	89.0
k141_476829_2	SARG|gi|495067432|ref|WP_007792257.1|	32.4	259	729	647	1.59e-18	89.0
k141_476829_2	SARG|gi|1020141879|ref|WP_063264839.1|	30.8	260	729	647	2.09e-18	88.6
k141_476829_2	SARG|gi|938460528|ref|WP_054624864.1|	30.9	259	729	647	2.77e-18	88.2
k141_476829_2	SARG|gi|742378414|ref|WP_038857601.1|	30.5	259	729	647	2.77e-18	88.2
k141_476829_3	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	27.6	174	224	574	8.32e-13	65.9
k141_265576_7	SARG|YP_001176128	40.1	222	255	646	2.60e-36	134
k141_265576_7	SARG|gi|974588181|ref|WP_059178476.1|	39.6	222	255	646	4.88e-36	134
k141_265576_7	SARG|gi|757782629|ref|WP_043001213.1|	38.7	222	255	648	6.75e-36	133
k141_265576_7	SARG|gi|992390012|ref|WP_061077002.1|	38.7	222	255	648	6.75e-36	133
k141_265576_7	SARG|gi|763407609|ref|WP_044264203.1|	38.7	222	255	648	6.75e-36	133
k141_265576_7	SARG|gi|754927849|ref|WP_042284850.1|	38.7	222	255	648	1.27e-35	132
k141_265576_7	SARG|gi|968563772|ref|WP_058587854.1|	38.3	222	255	648	1.73e-35	132
k141_265576_7	SARG|gi|817104523|ref|WP_046477871.1|	38.3	222	255	648	2.38e-35	132
k141_265576_7	SARG|gi|764278838|ref|WP_044327089.1|	38.3	222	255	648	2.38e-35	132
k141_265576_7	SARG|gi|763399392|ref|WP_044256358.1|	38.3	222	255	648	8.34e-35	130
k141_150573_14	SARG|L42544.gene.p01	27.5	665	694	651	3.19e-65	226
k141_150573_14	SARG|AAV80410	27.5	665	694	651	1.61e-64	224
k141_150573_14	SARG|NP_348076	27.1	695	694	652	1.57e-63	222
k141_150573_14	SARG|YP_002850805	26.7	681	694	652	1.09e-62	219
k141_150573_14	SARG|ZP_02952732	26.8	686	694	652	1.50e-62	219
k141_150573_14	SARG|ZP_02632674	26.8	686	694	660	1.72e-62	219
k141_150573_14	SARG|L20800.gene.p01	26.8	686	694	652	5.43e-62	218
k141_150573_14	SARG|AJ514254.gene.p01	25.6	676	694	640	2.52e-54	196
k141_150573_14	SARG|ABB70056	26.6	672	694	639	7.95e-53	192
k141_150573_14	SARG|gi|164612278|gb|ABY63608.1|	26.3	676	694	639	1.09e-52	191
k141_728881_11	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	27.0	259	268	343	5.86e-23	95.1
k141_728881_11	NCBI|WP_011116970.1|1|1|tetAB_B|tetAB_B|efflux|2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_TetAB_subunit_B|AMR|tetracycline	25.1	223	268	528	2.08e-09	56.6
k141_728881_11	SARG|gb|AAK76137.1|ARO:3000024|patA	22.9	240	268	564	3.84e-09	55.8
k141_728881_11	SARG|gb|CDO61516.1|ARO:3003949|efrB	30.0	160	268	362	9.66e-09	54.3
k141_728881_11	SARG|gi|817122037|ref|WP_046494699.1|	22.2	248	268	613	1.31e-07	51.2
k141_728881_11	SARG|AXF35727.1	24.1	203	268	497	9.26e-06	45.4
k141_728881_12	NCBI|QHA94808.1|1|1|narA|narA||1|MADURAMICIN/NARASIN/SALINOMYCIN|IONOPHORE|ionophore_ABC_transporter_ATP-binding_subunit_NarA|AMR|ionophore	27.9	222	235	293	3.61e-22	91.3
k141_728881_12	SARG|gb|AAK76137.1|ARO:3000024|patA	23.5	221	235	564	8.91e-17	77.8
k141_825650_5	megares|MEG_3295|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|ILES_1	40.2	1109	1068	1107	1.00e-272	794
k141_825650_5	SARG|gb|ADP36409.1|ARO:3003730|Bifidobacteria	40.2	1109	1068	1107	1.00e-272	794
k141_825650_5	megares|MEG_4091|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPB_1	39.7	1016	1068	1033	6.16e-263	766
k141_825650_5	SARG|gb|AEY83581|ARO:3000510|mupB	39.7	1016	1068	1033	6.16e-263	766
k141_825650_5	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	38.5	1019	1068	1024	1.17e-260	760
k141_825650_5	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	38.5	1019	1068	1024	1.17e-260	760
k141_825650_5	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	38.3	1019	1068	1024	1.47e-258	754
k141_825650_5	SARG|gb|CAA53189|ARO:3000521|mupA	38.3	1019	1068	1024	1.47e-258	754
k141_536744_4	NCBI|WP_003479690.1|1|1|tetA(P)|tetA(P)|efflux|2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_MFS_transporter_TetA(P)|AMR|tetracycline	25.9	189	363	420	5.18e-06	47.0
k141_882732_3	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	41.2	228	237	231	5.49e-57	180
k141_882732_3	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	40.4	230	237	232	5.84e-54	172
k141_882732_3	CARD|gb|ATC67679.1|ARO:3000838|arlR	39.3	219	237	219	4.50e-53	169
k141_882732_3	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	40.4	228	237	232	1.32e-52	169
k141_882732_3	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	40.4	228	237	232	1.32e-52	169
k141_882732_3	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	40.3	226	237	229	3.87e-51	165
k141_882732_3	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	37.7	220	237	228	7.52e-51	164
k141_882732_3	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	39.7	234	237	235	1.47e-49	161
k141_882732_3	CARD|gb|AAD51348.1|ARO:3003066|smeR	39.5	223	237	229	4.93e-49	159
k141_882732_3	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	36.6	227	237	231	2.08e-48	158
k141_882732_14	SARG|AY082011.1.gene6.p01	36.0	278	323	323	2.88e-36	132
k141_882732_14	SARG|gi|552942232|ref|WP_023043160.1|	36.0	278	323	323	5.62e-36	131
k141_882732_14	SARG|AAD51059	33.0	321	323	323	5.62e-36	131
k141_882732_14	SARG|AAR37059	32.9	319	323	323	2.14e-35	129
k141_882732_14	SARG|AAD41881	35.6	278	323	323	2.14e-35	129
k141_882732_14	SARG|NP_878015	35.0	277	323	322	7.93e-35	128
k141_882732_14	SARG|AAD42183	33.0	321	323	322	1.11e-34	127
k141_882732_14	SARG|YP_002333394	33.8	284	323	323	8.31e-34	125
k141_882732_14	SARG|AF310956.2.gene5.p01	33.5	284	323	323	3.14e-33	124
k141_882732_14	NCBI|WP_063856701.1|1|1|vanH-B|vanH-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-B|AMR|glycopeptide	33.5	284	323	323	3.14e-33	124
k141_882732_27	SARG|gi|488374619|ref|WP_002444004.1|	25.3	431	451	452	1.55e-47	168
